August 20th 2025
The risk for MDD is greatest in the first month after diagnosis and the absolute risk remains elevated even 20 years later, making early detection and treatment imperative.
VAS-COG: Sertraline Shows Promise for Improving Executive Function in Dementia
July 16th 2007SAN ANTONIO -- High-dose therapy with the selective serotonin reuptake inhibitor (SSRI) sertraline resulted in statistically and clinically significant improvement in isolated impaired executive function in older patients.
Ventricular Tachycardia in Acute Myocardial Infarction
July 1st 2007A 67-year-old woman arrived via ambulance in ventricular tachycardia. She had been experiencing crushing substernal chest pain and shortness of breath that had worsened over the past several hours. She received oxygen (by mask) and lidocaine (100 mg intravenously) en route to the emergency department (ED), but there was no change in the rhythm.
Studies Find No Link Between SSRIs and Congenital Heart Disease
June 27th 2007BOSTON -- Use of selective serotonin-reuptake inhibitors (SSRIs) during the first trimester of pregnancy did not significantly increase the risk of congenital heart defects overall, despite FDA and drug maker warnings to the contrary.